Leveljump Healthcare Past Earnings Performance
Past criteria checks 0/6
Leveljump Healthcare has been growing earnings at an average annual rate of 22.2%, while the Healthcare industry saw earnings growing at 6.2% annually. Revenues have been growing at an average rate of 30.6% per year.
Key information
22.2%
Earnings growth rate
136.7%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 30.6% |
| Return on equity | -45.1% |
| Net Margin | -13.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Leveljump Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 15 | -2 | 3 | 0 |
| 31 Mar 24 | 14 | -2 | 3 | 0 |
| 31 Dec 23 | 13 | -2 | 3 | 0 |
| 30 Sep 23 | 11 | -1 | 2 | 0 |
| 30 Jun 23 | 11 | 0 | 2 | 0 |
| 31 Mar 23 | 10 | 0 | 2 | 0 |
| 31 Dec 22 | 9 | 0 | 2 | 0 |
| 30 Sep 22 | 8 | -1 | 3 | 0 |
| 30 Jun 22 | 8 | -1 | 3 | 0 |
| 31 Mar 22 | 7 | -2 | 3 | 0 |
| 31 Dec 21 | 7 | -2 | 4 | 0 |
| 30 Sep 21 | 6 | -13 | 3 | 0 |
| 30 Jun 21 | 6 | -13 | 3 | 0 |
| 31 Mar 21 | 6 | -12 | 2 | 0 |
| 31 Dec 20 | 5 | -12 | 1 | 0 |
| 30 Sep 20 | 5 | 0 | 1 | 0 |
| 30 Jun 20 | 5 | 0 | 1 | 0 |
| 31 Mar 20 | 5 | 0 | 1 | 0 |
| 31 Dec 19 | 5 | 0 | 1 | 0 |
| 31 Dec 18 | 4 | 0 | 1 | 0 |
Quality Earnings: JMPH.F is currently unprofitable.
Growing Profit Margin: JMPH.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: JMPH.F is unprofitable, but has reduced losses over the past 5 years at a rate of 22.2% per year.
Accelerating Growth: Unable to compare JMPH.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: JMPH.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (8%).
Return on Equity
High ROE: JMPH.F has a negative Return on Equity (-45.08%), as it is currently unprofitable.